
LifeMatrix Technologies
LifeMatrix Technologies AG | Zürich.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
CHF150k | Grant | ||
Total Funding | 000k |
Related Content
LifeMatrix Technologies AG is a high-tech startup specializing in bioengineering technology to develop human replacement tissues for cardiovascular implants. Spun out from the Institute for Regenerative Medicine at the University of Zurich, the company focuses on creating next-generation implants that grow and regenerate with patients, addressing the challenges of cardiovascular diseases. LifeMatrix operates in the medical biomimetic device market, targeting healthcare providers and institutions that require advanced solutions for heart valve replacements. As a pre-revenue company, LifeMatrix is currently in the development phase, leveraging its expertise in cardiovascular tissue engineering and entrepreneurial acumen to position itself as a key player in the regenerative medicine sector. The business model revolves around the commercialization of its proprietary bioengineering technology, aiming to generate revenue through partnerships, licensing agreements, and direct sales to medical institutions.
Keywords: bioengineering, cardiovascular, implants, regenerative, tissue engineering, heart valves, biomimetic, pre-revenue, medical devices, healthcare.